His detailed understanding of highly technical manufacturing work flows and products is complemented by a proven track record of successfully creating organizations, product lines, technologies and processes to maximize performance. Emily Leproust is currently Chief Executive Officer and Director - Twist Bioscience (org chart) Chief Executive Officer and Director - Twist Bioscience (Organigramme) Créer une alerte pour suivre le parcours de Emily Leproust. Prior to Operon, he founded Xeragon, an international provider of RNA synthesis and bioinformatics products (now QIAGEN). Today, she's working on building robotic clones of humans. He holds a PhD in Nucleic Acid Chemistry from Southampton University and a BSc Hons in Chemistry from Heriot-Watt University.Chief Legal Officer, Chief Ethics and Compliance Officer, Senior Vice President and SecretaryChief Legal Officer, Chief Ethics and Compliance Officer, Senior Vice President and SecretaryMark joined Twist Bioscience in August 2016, bringing more than 25 years of experience as a seasoned legal officer with extensive technology and biotechnology industry expertise at Fortune 500 companies. He served as an adjunct professor of Law at Pepperdine University School of Law in Malibu, California where he taught Food and Drug Law. Dr. Leproust designed and developed multiple commercial synthesis platforms to streamline microarray manufacturing and fabrication. San Francisco, CA 94158
As VP of hardware engineering at Complete Genomics, he built their sequencing technology and delivered three generations of human genome chips and sequencers. She earned her Ph.D. in organic chemistry from the University of Houston and her M.Sc. He is an author of over 30 peer reviewed papers and 40 issued patents in the antibody space.Paula Green is an experienced human resources executive with a track record of developing and delivering high-impact people strategies, solutions, processes and tools that support leadership competencies to empower a high performing organization. In 2015, she was named one of Foreign Policy’s 100 Leading Global Thinkers for fast-tracking the building blocks of life, and Fast Company named her one of the most creative people in business for synthesizing DNA faster than ever. in industrial chemistry from the Lyon School of Industrial Chemistry in France.The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.PMWC is the most comprehensive precision medicine conference.
He is an author of several issued patents.Patrick has a strong track record of high-growth sales in bioreagent, B2B and custom manufacturing organizations. Biographie de Emily Leproust Actualisation : 13 janvier 2020. She was also appointed as Chair of our board of directors effective as of October 2018. Before that, he spent 20 years in positions of increasing responsibility in the legal department at Amgen, where his last role was vice president and associate general counsel. Twist Bioscience serves patients in the United States.455 Mission Bay Blvd South Emily a été Director Applications and Chemistry R&D, Genomics chez Agilent Technologies. Preceding his time at Eurofins, he served as Chief Information Officer of Operon Biotechnologies, Inc. where he built a global information technology team and developed and deployed a CRM, an e-commerce and a business intelligence system. Prior to Twist Bioscience, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center, which discovers novel antibody therapeutics for its clients. Dr. Leproust is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data storage, agricultural biology and industrial chemicals. Emily Leproust Biography As an early pioneer in the high throughput synthesis and sequencing of DNA, Dr. Leproust is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data storage, agricultural biology and industrial chemicals. Suite 545 As an early pioneer in the high throughput synthesis and sequencing of DNA, Dr. Leproust is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data storage, agricultural biology and industrial chemicals.